Acute caffeine administration effect on brain activation patterns in mild cognitive impairment

Journal of Alzheimer's Disease

Volumn 41, Issue 1, 2014, Pages 101-112

  Haller, Sven ^a   Montandon, Marie Louise ^a   Rodriguez, Cristelle ^a   Moser, Dominik ^a   Toma, Simona ^a   Hofmeister, Jeremy ^a   Sinanaj, Indrit ^a   Lovblad, Karl Olof ^a   Giannakopoulos, Panteleimon ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Blood oxygenation level dependent; caffeine; functional magnetic resonance imaging; mild cognitive impairment

Indexed keywords

CAFFEINE; PLACEBO; CENTRAL STIMULANT AGENT;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TASK PERFORMANCE; WHITE MATTER; WORKING MEMORY; BRAIN; BRAIN CIRCULATION; BRAIN MAPPING; CROSSOVER PROCEDURE; DIFFUSION TENSOR IMAGING; DRUG EFFECTS; NERVE TRACT; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SHORT TERM MEMORY; SIGNAL PROCESSING;

AGED; BRAIN; BRAIN MAPPING; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBROVASCULAR CIRCULATION; CROSS-OVER STUDIES; DIFFUSION TENSOR IMAGING; FEMALE; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; MILD COGNITIVE IMPAIRMENT; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; REACTION TIME; SIGNAL PROCESSING, COMPUTER-ASSISTED; WHITE MATTER;

EID: 84902272235     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-132360     Document Type: Article

References (75)

1. Lindsay J, Laurin D, Verreault R, Hebert R, Helliwell B, Hill GB, McDowell I (2002) Risk factors for Alzheimer's disease: A prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156, 445-453.
2. Maia L, de Mendonca A (2002) Does caffeine intake protect from Alzheimer's disease? Eur J Neurol 9, 377-382.
3. van Gelder BM, Buijsse B, Tijhuis M, Kalmijn S, Giampaoli S, Nissinen A, Kromhout D (2007) Coffee consumption is inversely associated with cognitive decline in elderly European men: The FINE Study. Eur J Clin Nutr 61, 226-232.
4. Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M (2009) Midlife coffee and tea drinking and the risk of late-life dementia: A population-based CAIDE study. J Alzheimers Dis 16, 85-91.
5. Ritchie K, Artero S, Portet F, Brickman A, Muraskin J, Beanino E, Ancelin ML, Carriere I (2010) Caffeine, cognitive functioning, and white matter lesionsinthe elderly: Establishing causality from epidemiological evidence. J Alzheimers Dis 20 (Suppl 1), S161-S166.
6. Chu YF, Chang WH, Black RM, Liu JR, Sompol P, Chen Y, Wei H, Zhao Q, Cheng IH (2012) Crude caffeine reduces memory impairment and amyloid beta (1-42) levels in an Alzheimer's mouse model. Food Chem 135, 2095-2102.
7. Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J (2006) Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience 142, 941-952.
8. Arendash GW, Mori T, Cao C, Mamcarz M, Runfeldt M, Dickson A, Rezai-Zadeh K, Tane J, Citron BA, Lin X, Echeverria V, Potter H (2009) Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. J Alzheimers Dis 17, 661-680.
9. Dall'Igna OP, Fett P, Gomes MW, Souza DO, Cunha RA, Lara DR (2007) Caffeine and adenosine A (2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice. Exp Neurol 203, 241-245.
10. Espinosa J, Rocha A, Nunes F, Costa MS, Schein V, Kazlauckas V, Kalinine E, Souza DO, Cunha RA, Porci-uncula LO (2013) Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia. J Alzheimers Dis 34, 509-518.
11. Cao C, Loewenstein DA, Lin X, Zhang C, Wang L, Duara R, Wu Y, Giannini A, Bai G, Cai J, Greig M, Schofield E, Ashok R, Small B, Potter H, Arendash GW (2012) High Blood caffeine levels in MCI linked to lack of progression to dementia. J Alzheimers Dis 30, 559-572.
12. Zeitlin R, Patel S, Burgess S, Arendash GW, Echeverria V (2011) Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice. Brain Res 1417, 127-136.
13. Cao C, Wang L, Lin X, Mamcarz M, Zhang C, Bai G, Nong J, Sussman S, Arendash G (2011) Caffeine synergizes with another coffee component to increase plasma GCSF: Linkage to cognitive benefits in Alzheimer's mice. J Alzheimers Dis 25, 323-335.
14. Prasanthi JR, Dasari B, Marwarha G, Larson T, Chen X, Geiger JD, Ghribi O (2010) Caffeine protects against oxida-tive stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radic Biol Med 49, 1212-1220.
15. Canas PM, Porciuncula LO, Cunha GM, Silva CG, Machado NJ, Oliveira JM, Oliveira CR, Cunha RA (2009) Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway. J Neurosci 29, 14741-14751.
16. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51, 83-133.
17. Dunwiddie TV, Masino SA (2001) The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24, 31-55.
18. Costenla AR, Diogenes MJ, Canas PM, Rodrigues RJ, Nogueira C, Maroco J, Agostinho PM, Ribeiro JA, Cunha RA, de Mendonca A (2011) Enhanced role of adenosine A (2A) receptors in the modulation of LTP in the rat hippocampus upon ageing. Eur J Neurosci 34, 12-21.
19. Laurienti PJ, Field AS, Burdette JH, Maldjian JA, Yen YF, Moody DM (2002) Dietary caffeine consumption modulates fMRI measures. Neuroimage 17, 751-757.
20. Pelligrino DA, Xu HL, Vetri F (2010) Caffeine and the control of cerebral hemodynamics. J Alzheimers Dis 20 (Suppl 1), S51-S62.
21. Rack-Gomer AL, Liau J, Liu TT (2009) Caffeine reduces resting-state BOLD functional connectivity in the motor cortex. Neuroimage 46, 56-63.
22. Wong CW, Olafsson V, Tal O, Liu TT (2012) Anti-correlated networks, global signal regression, and the effects of caffeine in resting-state functional MRI. Neuroimage 63, 356-364.
23. Tal O, Diwakar M, Wong CW, Olafsson V, Lee R, Huang MX, Liu TT (2013) Caffeine-induced global reductions in resting-state BOLD connectivity reflect widespread decreases in MEG connectivity. Front Hum Neurosci 7, 63.
24. Perthen JE, Lansing AE, Liau J, Liu TT, Buxton RB (2008) Caffeine-induced uncoupling of cerebral blood flow and oxy-genmetabolism:Acalibrated BOLD fMRIstudy. Neuroimage 40, 237-247.
25. Griffeth VE, Perthen JE, Buxton RB (2011) Prospects for quantitative fMRI: Investigating the effects of caffeine on baseline oxygen metabolism and the response to a visual stimulus in humans. Neuroimage 57, 809-816.
26. Diukova A, Ware J, Smith JE, Evans CJ, Murphy K, Rogers PJ, Wise RG (2012) Separating neural and vascular effects of caffeine using simultaneous EEG-FMRI: Differential effects of caffeine on cognitive and sensorimotor brain responses. Neuroimage 62, 239-249.
27. Portas CM, Rees G, Howseman AM, Josephs O, Turner R, Frith CD (1998) A specific role for the thalamus in mediating the interaction of attention and arousal in humans. J Neurosci 18, 8979-8989.
28. Koppelstaetter F, Poeppel TD, Siedentopf CM, Ischebeck A, Verius M, Haala I, Mottaghy FM, Rhomberg P, Golaszewski S, Gotwald T, Lorenz IH, Kolbitsch C, Felber S, Krause BJ (2008) Does caffeine modulate verbal working memory processes? An fMRI study. Neuroimage 39, 492-499.
29. Klaassen EB, de Groot RH, Evers EA, Snel J, Veerman EC, Ligtenberg AJ, Jolles J, Veltman DJ (2013) The effect of caffeine on working memory load-related brain activation in middle-aged males. Neuropharmacology 64, 160-167.
30. Haller S, Rodriguez C, Moser D, Toma S, Hofmeister J, Sinanaj I, Van De Ville D, Giannakopoulos P, Lovblad KO (2013) Acute caffeine administration impact on working memory-related brain activation and functional connectivity in the elderly: A BOLD and perfusion MRI study. Neuro-science 250, 364-371.
31. Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack CR Jr, Schuff N, Weiner MW, Thompson PM, Alzheimer's Disease Neuroimaging I (2009) Automated 3D mapping of hippocam-pal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp 30, 2766-2788.
32. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
33. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67, 361-370.
34. Barberger-Gateau P, Commenges D, Gagnon M, Letenneur L, Sauvel C, Dartigues JF (1992) Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc 40, 1129-1134.
35. Wechsler D (1997) WAIS-III. Wechsler Adult Intelligence Scale-Third Edition. Harcourt Assessment, San Antonio, TX.
36. Reitan RM (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8, 271-276.
37. Wechsler D (1997) Wechsler Memory Scale-Third Edition (WMS-III UK) Administration and Scoring Manual. The Psychological Corporation, San Antonio, TX.
38. Adam S, Van der Linden M, Poitrenaud J, Kalafat M, GRE-MEM (2004) L'épreuve de rappel indicé à 48 items (RI-48). In: L'évaluation des troubles de la mémoire: Présentation de quatres tests de mémoire épisodique (avec leur étalonnage), Van der Linden M, GREMEM. eds. Solal 2, Marseille.
39. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G (1981) Wisconsin card sorting test manual, revised and expanded, PAR Psychological Assessment Resources, Inc.
40. Cardebat D, Doyon B, Puel M, Goulet P, Joanette Y (1990) [Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level]. Acta Neurol Belg 90, 207-217.
41. Kaplan EF, Goodglass H, Weintraub S (1983) The Boston naming test. Lea & Febiger, Philadelphia.
42. Ghent L (1956) Perception of overlapping and embedded figures by children of different ages. Am J Psychol 69, 575-587.
43. Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fil-lenbaum G, Heyman A (1994) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative studyofthe neuropsychological battery. Neurology 44, 609-614.
44. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140, 566-572.
45. Petersen RC (2004) Mild cognitive impairmentasadiagnostic entity. J Intern Med 256, 183-194.
46. Mulderink TA, Gitelman DR, Mesulam MM, Parrish TB (2002) On the use of caffeine as a contrast booster for BOLD fMRI studies. Neuroimage 15, 37-44.
47. Liu TT, Behzadi Y, Restom K, Uludag K, Lu K, Buracas GT, Dubowitz DJ, Buxton RB (2004) Caffeine alters the temporal dynamics of the visual BOLD response. Neuroimage 23, 1402-1413.
48. Behzadi Y, Liu TT (2006) Caffeine reduces the initial dip in the visual BOLD response at 3 T. Neuroimage 32, 9-15.
49. Owen AM, McMillan KM, Laird AR, Bullmore E (2005) N-back working memory paradigm: A meta-analysis of normative functional neuroimaging studies. Hum Brain Mapp 25, 46-59.
50. Beckmann CF, Jenkinson M, Smith SM (2003) General multilevel linear modeling for group analysisinFMRI. Neuroimage 20, 1052-1063.
51. Woolrich MW, Behrens TE, Beckmann CF, Jenkinson M, Smith SM (2004) Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage 21, 1732-1747.
52. Woolrich M (2008) Robust group analysis using outlier inference. Neuroimage 41, 286-301.
53. Beckmann CF, Smith SM (2005) Tensorial extensionsofinde-pendent component analysis for multisubject FMRI analysis. Neuroimage 25, 294-311.
54. Hyvarinen A (1999) Fast and robust fixed-point algorithms for independent component analysis. IEEE Trans Neural Netw 10, 626-634.
55. Smith SM, Nichols TE (2009) Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44, 83-98.
56. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE (2006) Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage 31, 1487-1505.
57. Smith SM, Johansen-Berg H, Jenkinson M, Rueckert D, Nichols TE, Miller KL, Robson MD, Jones DK, Klein JC, Bartsch AJ, Behrens TE (2007) Acquisition and voxelwise analysis of multi-subject diffusion data with tract-based spatial statistics. Nat Protoc 2, 499-503.
58. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 (Suppl 1), S208-S219.
59. Landau SM, Lal R, O'Neil JP, Baker S, Jagust WJ (2009) Striatal dopamine and working memory. Cereb Cortex 19, 445-454.
60. Faraco CC, Puente AN, Brown C, Terry DP, Stephen Miller L (2013) Lateral temporal hyper-activation as a novel biomarker of mild cognitive impairment. Neuropsychologia 51, 2281-2293.
61. Dickerson BC, Sperling RA (2008) Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: Insights from functional MRI studies. Neuropsychologia 46, 1624-1635.
62. Pihlajamaki M, Jauhiainen AM, Soininen H (2009) Structural and functional MRI in mild cognitive impairment. Curr Alzheimer Res 6, 179-185.
63. Woodard JL, Seidenberg M, Nielson KA, Antuono P, Guidotti L, Durgerian S, Zhang Q, Lancaster M, Hantke N, Butts A, Rao SM (2009) Semantic memory activation inamnestic mild cognitive impairment. Brain 132, 2068-2078.
64. Braver TS, Cohen JD, Nystrom LE, Jonides J, Smith EE, Noll DC (1997) A parametric study of prefrontal cortex involvement in human working memory. Neuroimage 5, 49-62.
65. D'Esposito M, Aguirre GK, Zarahn E, Ballard D, Shin RK, Lease J (1998) Functional MRI studies of spatial and nonspatial working memory. Brain Res Cogn Brain Res 7, 1-13.
66. Smith EE, Jonides J, Marshuetz C, Koeppe RA (1998) Components of verbal working memory: Evidence from neu-roimaging. Proc Natl Acad Sci USA 95, 876-882.
67. Callicott JH, Mattay VS, Bertolino A, Finn K, Coppola R, Frank JA, Goldberg TE, Weinberger DR (1999) Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 9, 20-26.
68. Jansma JM, Ramsey NF, Coppola R, Kahn RS (2000) Specific versus nonspecific brain activity in a parametric N-back task. Neuroimage 12, 688-697.
69. Cameron OG, Modell JG, Hariharan M (1990) Caffeine and human cerebral blood flow: A positron emission tomography study. Life Sci 47, 1141-1146.
70. Vidyasagar R, Greyling A, Draijer R, Corfield DR, Parkes LM (2013) The effect of black tea and caffeine on regional cerebral blood flow measured with arterial spin labeling. J Cereb Blood Flow Metab 33, 963-968.
71. Arendash GW, Cao C (2010) Caffeine and coffee as therapeutics against Alzheimer's disease. J Alzheimers Dis 20 (Suppl 1), S117-S126.
72. Gelber RP, Petrovitch H, Masaki KH, Ross GW, White LR (2011) Coffee intake in midlife and risk of dementia and its neuropathologic correlates. J Alzheimers Dis 23, 607-615.
73. Cunha RA, Agostinho PM (2010) Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline. J Alzheimers Dis 20 (Suppl 1), S95-S116.
74. Chen X, Ghribi O, Geiger JD (2010) Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases. J Alzheimers Dis 20 (Suppl 1), S127-S141.
75. Field AS, Laurienti PJ, Yen YF, Burdette JH, Moody DM (2003) Dietary caffeine consumption and withdrawal: Confounding variables in quantitative cerebral perfusion studies? Radiology 227, 129-135.